Jadel Kratz | BrazMedChem 2022 | Galoá Proceedings

Drugs for Neglected Diseases initiative (DNDi)

Jadel Kratz

Is this your profile? Do login to access your certificates

Pharmacophore modeling, QSAR, and docking studies of Indole Derivatives in the Hit-to-Lead Stage for Chagas Disease
Eun Lee ¹
Ramon Guerra de Oliveira ¹
Marco Aurélio Dessoy ¹
Luiza Cruz ²
Deborah Araújo dos Santos ¹
María Cruz Mollo ¹
Jadel Kratz ³
Luiz Carlos Dias ⁴
¹ Universidade Estadual de Campinas
² Drugs for Neglected Diseases initiative
³ Drugs for Neglected Diseases initiative (DNDi)
⁴ UNICAMP
Vol 2, 2022 -
152551

2. Medicinal Chemistry of Synthetic Compounds

Poster
Antitrypanosomal Benzoxazinone Series: Hit-to-Lead Campaign and Multiparametric Optimization
María Cruz Mollo ¹
Luiza Cruz ²
Marco Aurélio Dessoy ¹
Eun Lee ¹
Ramon Guerra de Oliveira ¹
Francielle Dutra ¹
Simone Duarte ³
Renata Krogh ³
Leonardo Luiz Gomes Ferreira ³
Rafael Chelucci ³
Clarissa Feltrin ³
Carolina Borsoi Moraes ⁴
Adriano D. Andricopulo ³
Jadel Kratz ⁵
Peter Sjö ²
Charles Mowbray ⁶
Luiz Carlos Dias ⁷
¹ Universidade Estadual de Campinas
² Drugs for Neglected Diseases initiative
³ Universidade de São Paulo
⁴ Universidade Federal de São Paulo
⁵ Drugs for Neglected Diseases initiative (DNDi)
⁶ Drugs for Nedlected Diseases initiative (DNDi)
⁷ UNICAMP
Vol 2, 2022 -
152552

2. Medicinal Chemistry of Synthetic Compounds

Oral

Co-authors (18)

Publications in other proceedings

BrazMedChem 2019
Antitrypanosomal aminobenzimidazoles: hit to lead expansion of new chemical entities against Trypanosoma cruzi and Leishmania infantum